Document is current
Any future updates will be listed below
-
Authors
Dai, Rong
Cheng, Meng
Peng, Chu-Yi
Cao, Ze-Ping
Jin, Hua
Wang, Dong
Wang, Yi-Ping
Zhang, Lei https://orcid.org/0009-0005-9012-9952
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82274307 and 82004165)
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 11 April 2025
First Online: 23 April 2025
Declarations
:
: All animal protocols were approved by the Animal Ethics Committee of Anhui University of Traditional Chinese Medicine (“P-selectin/PSGL-1 based MAPK signaling pathway for vascular endothelial cell injury to explore the mechanism of promoting renal fibrosis”, No. AHUCM-rats-2019003, approved March 15, 2019). All studies involving human samples were approved by the Ethics Committee on Human Subjects of the First Affiliated Hospital of Anhui University of Chinese Medicine (“Exploring the intervention effect of Qingshen granules in patients with portal nephropathy based on immunoinflammation-mediated mechanisms”, KY2019005, approved May 5, 2019).
: Not applicable.
: The authors have declared that no competing interest exists.
